z-logo
open-access-imgOpen Access
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice
Author(s) -
Yudong Song,
Luke F. Bugada,
Ruiting Li,
Hongxiang Hu,
Luchen Zhang,
Chengyi Li,
Hebao Yuan,
Krishani Rajanayake,
Nathan A. Truchan,
Fei Wen,
Wei Gao,
Duxin Sun
Publication year - 2022
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.abl3649
Subject(s) - paclitaxel , breast cancer , cancer research , albumin , medicine , cancer , pi3k/akt/mtor pathway , pharmacology , chemistry , biochemistry , signal transduction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom